Kuzari Group

ONA Designs International, LLC specializes in handcrafted premium bags and accessories tailored for photographers. Founded in 2010 and based in New York, the company offers a diverse range of products, including messenger bags, shoulder bags, rolling bags, briefcases, backpacks, and small goods. ONA's offerings are designed to protect essential photography equipment while providing style and functionality. The products are available through various retail stores and an online platform, allowing the company to reach customers both domestically and internationally.

Precipio Diagnostics is a cancer diagnostics company based in New Haven, Connecticut, specializing in clinical diagnostic services for hematopoietic cancers. The company offers advanced diagnostic products, including the HemeScreen panel for genetic mutation testing and the IV-Cell media, which enhances the accuracy of laboratory results. Precipio serves a diverse clientele, including oncologists, hospitals, reference laboratories, and pharmaceutical companies. In its commitment to improving cancer care, the company collaborates with prominent academic institutions such as the Yale School of Medicine and Dana-Farber Cancer Institute, fostering connections between physicians and leading pathologists. With laboratories in New Haven and Omaha, Precipio aims to reduce instances of cancer misdiagnoses and provide essential diagnostics to oncologists across the United States.

New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs). The company aims to address significant therapeutic needs by offering innovative, controlled-release formulations that enhance dosing precision, safety, efficacy, and patient convenience. NHP's product pipeline leverages proprietary technologies and intellectual property licensed from Yale University, allowing the development of specialty drugs for new therapeutic indications. Through its innovative platform, NHP seeks to provide premium pharmaceutical solutions that meet the evolving needs of patients and healthcare providers.